Peter Lee

Vector Biomed is a state-of-the-art custom vector design and GMP manufacturing company.

Raised $15,000,000.00 from Viking Global Investors and Casdin Capital.

Xcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance.

Raised $39,600,000.00 from LabCorp.

IVexSol is a lentiviral vector production platform that supplies a consistent source of vectors for successful gene therapy programs.

Raised $39,050,000.00 from BioLife Solutions, Bristol-Myers Squibb, Asahi Kasei Medical Europe, Charles River Laboratories International, Casdin Capital, Casdin Capital and BioLife Solutions.

Invetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases.

Raised $85,750,000.00 from Eight Roads Ventures, Tekla Capital Management, F-Prime Capital, Novo Holdings, Anterra Capital, Google Ventures and Casdin Capital.

Molecular Assemblies is developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products.

Raised $91,167,744.00 from GE Healthcare, Defense Advanced Research Projects Agency and National Human Genome Research Institute.

Multiply Labs deploys advanced robotics technology to manufacture personalized pharmaceutical capsules.

Raised $22,700,000.00 from Casdin Capital, Lux Capital, Founders Fund, Pathfinder, Garage Capital, Alice Zhang and Fifty Years.

Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry.